Oncolytics Biotech Inc ONCY

Leedjonesgable: Oncolytics Biotech Inc. | ONCY/ONC-TSX

[Noteable]

Even before GOBLET-1 data were available, we endorsed Oncolytics’ decision to test pelareorep in advanced pancreatic cancer based on prior clinical history and on medical imperative to develop therapies that are superior to standard-of-care. 

https://leedejonesgable.com/wp-content/uploads/ONC_2022_11_15.pdf

[Noteable]

Leede Jones Gable Inc. acted as underwriter and bookrunner (the "Underwriter") in accordance with the terms of an underwriting agreement between the Company and the Underwriter dated as of August 1, 2023 (the "Underwriting Agreement"), pursuant to which Oncolytics issued 6,667,000 units (the "Equity Units") for gross proceeds to the Company of US$15,000

[Noteable]

So why would LeedJomesGable have some entity investing US$ 17.5 million at this point? Well either that entity is covering a hugh short position OR that entity sees the unrealized value in the stock right now!

[venture009]

Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln Park Capital, LLC :: Oncolytics Biotech, Inc. (ONCY) Not certain if this agreement was fully exercised but it was for considerably more money at a much higher price and also begs the question why did Lincoln Capital get involved. Regardless here we are 5 years with a deal for much less money

[Noteable]

Lincoln Park Capital used the purchase to cover ther shot positions in the stock. This was the legacy of Brad Thompson.

[Noteable]

Should read .. short positions 

[Noteable]

Lincoln Park Capital has been labeled a prolific "vulture fund" and Brad Thompson dragged the company into that toxic deal. https://utopiacap.com/lincoln-park-capital/

[Noteable]

Unlike Lincoln Park Capital, Leede Jones Gable is mid-size national investment firm with over 244 employees and US$ 3.5 Billion in investment holdings.